Medical Cannabis Gains Headway in Ireland
[dropcap class=”kp-dropcap”]I[/dropcap]n last year’s March issue of CULTURE, we told the story of Dr. William Brooke O’Shaughnessy, who introduced cannabis as a medicine in 1839. Over 100 years after O’Shaughnessy revealed to the western world the medical benefits of cannabis, his homeland remains in opposition of his findings, as cannabis is still medically illegal in Ireland. Cannabis became illegal in Ireland and the rest of the U.K. in 1928 following the 1925 Dangers of Drugs Act. However, doctors were able to prescribe cannabis for a while, until 1971 when the Misuse of Drugs Act was passed. Since then, cannabis has remained strictly illegal in Ireland, making access to the plant nearly impossible. Luckily, another Irishman and doctor, James Linden, has been leading the Dublin-based research firm GreenLight Health in a quest to make medical cannabis legal in Ireland, by highlighting its effects on various medical conditions.
With a number of people in Ireland suffering from conditions like Multiple Sclerosis (MS), glaucoma and cancer, the black market is their only source to turn to for medicine. As of last year, being in possession of a substance like cannabis resulted in a €2,750 fine and up to 12 months in prison. Seeing these ludicrous penalties, Linden and his group began working a campaign to address this issue to the government. With hopes of utilizing some fundraiser money for its campaign, GreenLight Health created a fundraising page on Indiegogo, where they were only able to raise €147. Although the amount of financial support shown to GreenLight Health was null, the team has found other investors Linden told CULTURE.
In an effort to revolutionize Ireland’s medical cannabis market, Linden and the team at GreenLight Health have been working hard, “researching and developing effective and affordable cannabis medicines,” according to Linden. As the only Irish pharmaceutical company dedicated to producing medical cannabis products, the team is currently implementing a trial of supplements designed to treat joint and muscle pain, as well as arthritis. Not only does GreenLight Health hope to improve the lives of those affected by conditions that are seemly only treatable with cannabis, the company hopes to create 500 research and development jobs within the next five years. When asked why he decided to start up a cannabis research firm, Linden explained in the podcast Newstalk, “Cannabis gives people relief from symptoms of cancer but it also gives people relief from chemotherapy but there is also research that shows THC, one of the cannabinoids in cannabis . . . directly impacts tumors and can kill cancerous cells.” He finished by saying, “that kind of research is breaking through and we realize that there’s an opportunity in Ireland, an English speaking country, good pharmaceutical exporting country, great knowledge based around research, door steps of Europe and America, to get a very interesting cannabis research and development company going here.”
While medical cannabis remains unobtainable for patients, in November 2015 the Irish government revealed plans to move towards decriminalization of substances like cannabis. Chief of Ireland’s national Drug Strategy Aodhán Ó Ríordáin, even expressed plans to open injection rooms as a way to show empathy towards heroin addicts. If empathy can be given to addicts of a substance with no known medicinal value, patients in need of medical cannabis in Ireland should not have to suffer much longer. Hopefully, with efforts put forth by Linden and his team, patients will have access to effective and cost affordable medicine without having to pay the penalties.
